"An assay of an organd cult derivd frm the pt's tumor ID'd optns, inc a combo of fulvestrant w/everolimus. The pt lived nrly 11 mo w/ths combo. The case emphszs clin utility of ex vivo drug tstng 2 ID prec tx 4 pts not helpd by #SOC." Go @SEngineMedicine!
8,546 followers
6,535 followers
New research: Case report: ex vivo tumor organoid drug testing identifies therapeutic options for stage IV ovarian carcinoma: Patients presenting with stage 4 ovarian carcinoma, including low-grade serous disease, have a poor prognosis.… https://t.co/oAA4Y
141 followers
Case Report: Ex vivo tumor organoid drug testing identifies therapeutic options for stage IV low-grade ovarian carcinoma https://t.co/n1GQwRM4jz